SLC5A2 and diabetes mellitus: This can representan important advancement, taking into consideration that nephropathyis a frequent severe chronic complication of DM, and the administrationof selective SGLT-2 inhibitors can produce only poor therapeutic effectsin the glycemic control of these patients.125,128